{
    "clinical_study": {
        "@rank": "83853", 
        "arm_group": {
            "arm_group_label": "30 children with UC", 
            "description": "This prospective pilot study of 30 pediatric subjects, that are indicated for standard colonoscopy due to follow-up of ulcerative colitis (UC), examines the Given Diagnostic System and the PillCam Colon Capsule in comparison to standard colonoscopy."
        }, 
        "brief_summary": {
            "textblock": "This prospective pilot study of 30 pediatric subjects, that are indicated for standard\n      colonoscopy due to follow-up of ulcerative colitis (UC), examines the Given Diagnostic\n      System and the PillCam Colon Capsule in comparison to standard colonoscopy.\n\n      This study aims\n\n        1. To evaluate and compare the accuracy of PillCam \u2122 Colon capsule endoscopy (PCCE) with\n           standard colonoscopy in the evaluation of colon in pediatric ulcerative colitis.\n\n        2. To evaluate the safety of PillCam \u2122 Colon capsule endoscopy (PCCE) in pediatric age."
        }, 
        "brief_title": "Evaluation Of The Pillcam\u2122 Colon Capsule Endoscopy (Pcce-2) In Pediatric Ulcerative Colitis", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Pediatrics, Colon Capsule Endoscopy", 
        "condition_browse": {
            "mesh_term": [
                "Colitis", 
                "Colitis, Ulcerative"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "ELIGIBILITY Ages Eligible for Study: 6-18 Years Genders Eligible for Study: Both Accepts\n        Healthy Volunteers: No\n\n        Inclusion criteria:\n\n        Subjects must meet one the following inclusion criteria to be eligible for enrollment into\n        this proposed study:\n\n          -  diagnosis of UC made at least 3 months before the enrolment;\n\n          -  subject was referred for standard colonoscopy and endoscopic follow-up in Ulcerative\n             colitis\n\n          -  signed informed consent. Exclusion criteria\n\n        The presence of any of the following will exclude a subject from study enrollment:\n\n          -  Subject has dysphagia\n\n          -  Subject has renal insufficiency\n\n          -  Subject is known or suspected structuring CD.\n\n          -  Subject has a cardiac pacemaker or other implanted electro medical devices.\n\n          -  Subject is expected to undergo MRI examination within 7 days after ingestion of the\n             capsule.\n\n          -  Subject has had prior abdominal surgery of the gastrointestinal tract other than\n             uncomplicated procedures that would be unlikely to lead to bowel obstruction based on\n             the clinical judgment of the investigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "6 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The Given\u00ae Diagnostic System offers an alternative approach for endoscopic visualization\n        of the colon using capsule endoscopy, a swallowable device which contains imagers, light\n        sources, a power source and a RF transmitter. Advantages of the Given\u00ae Diagnostic System\n        include the elimination of the need for conscious sedation, the minimally invasive,\n        painless nature of the exam, and the ability to pursue normal daily activities immediately\n        following the procedure. This prospective pilot study will evaluate the performance of\n        PCCE in visualizing the colon of children with UC. All subjects to be enrolled will be\n        appropriate candidates for standard colonoscopy based on their clinical indication.\n\n        Each subject will undergo PCCE.  PCCE results will be compared with that of a colonoscopy\n        procedure."
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 28, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01740349", 
            "org_study_id": "PCCE-2 GIVEN"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 10, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rome", 
                    "country": "Italy", 
                    "zip": "00161"
                }, 
                "name": "Sapienza - University of Rome"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "EVALUATION OF THE PILLCAM\u2122 COLON CAPSULE ENDOSCOPY (PCCE) IN PEDIATRIC ULCERATIVE COLITIS", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Accuracy parameters (sensitivity, specificity, NPV, PPV) of PCCE compared to standard colonoscopy in pediatric Ulcerative Colitis.", 
            "measure": "To evaluate and compare the accuracy of PillCam \u2122 Colon capsule endoscopy (PCCE) with standard colonoscopy in the evaluation of colon in pediatric ulcerative colitis.", 
            "safety_issue": "No", 
            "time_frame": "Day 3 (after colonoscopy and CCE-2)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01740349"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Azienda Policlinico Umberto I", 
            "investigator_full_name": "Giovanni Di Nardo", 
            "investigator_title": "EVALUATION OF THE PILLCAM\u2122 COLON CAPSULE ENDOSCOPY (PCCE) IN PEDIATRIC ULCERATIVE COLITIS", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Number, type and severity of adverse events with both PCCE and standard colonoscopy", 
            "measure": "To evaluate the safety of PillCam \u2122 Colon capsule endoscopy (PCCE) in pediatric age.", 
            "safety_issue": "Yes", 
            "time_frame": "Day 3 (after colonoscopy and CCE-2)"
        }, 
        "source": "Azienda Policlinico Umberto I", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Azienda Policlinico Umberto I", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2012"
    }
}